Drug Pricing Germany Plus V
Price determination of assistive products
Drug Pricing Germany Plus V – in a nutshell
The Drug Pricing Germany Plus V is an optional supplement to the Drug Pricing Tool Germany. It lists information on the billing of articles in accordance with national delivery contracts. These are for example:
- Medicinal products according to § 47 AMG
- Urine and blood test strips
- Assistive Products, dressings
- Medical devices (Annex V: Overview of prescribable medical devices)
- Dietetics (§ 31 SGB V diet and health food products, such as amino acid mixtures, protein hydrolysates, elementard diets, probe diets)
- References to approval limits
- Delivery exclusions of individual funds due to tenders according to § 127 SGB V
- supply contracts subject to Package arrangements
- Billing according to § 302 SGB V (including cash-specific billing numbers)
- Contract-specific billing of compression stockings
Plus V supports providers in the often very complicated and time-consuming price determination of Assistive Products
Suitable for:
Pharma Industry, Pharma Trade, Health Insurance, Regulatory
Source: ABDATA PHARMA-DATa-SERVICE
Eschborn, Germany
Related subscription
This database can be accessed after purchasing the subscription package ‘Drug Pricing’ or ‘Premium’
What customers say
These databases could also be interesting for you
Related posts
Drug Pricing Database Germany: A One-Stop Solution for Up-to-Date Pharmaceutical Prices
Drug pricing database Germany – these four words sum up a critical need in the pharmaceutical industry. In a market as regulated and dynamic as Germany’s, professionals across market access, pharmacovigilance, hospital pharmacy, and health insurance face the constant...
Pharma Pricing Germany: Navigating Costs, Compliance and Transparency
Pharmaceutical pricing in Germany is unique in Europe – offering initial free pricing yet governed by strict mechanisms like AMNOG benefit assessments, reference pricing, and rebate contracts. In this comprehensive guide, we explain pharma pricing in Germany for...
Pharmaceutical Market Access Germany: Navigating Approval, Pricing, and Reimbursement
Pharmaceutical market access in Germany is a critical step for any drug developer aiming to tap into Europe’s largest pharmaceutical market. With a population of 84 million and annual pharmaceutical revenues exceeding €56.9 billion in 2021, Germany offers vast...
